The Conversation (0)
Cleo Diagnostics Ltd (‘COV’) was admitted to the Official List of ASX on Friday, 18 August 2023. The securities of COV will commence quotation at 11:00 AM AEST on Tuesday, 22 August 2023.
COV raised $12,000,000 pursuant to the offer under its replacement prospectus dated 6 July 2023 by the issue of 60,000,000 shares at an issue price of $0.20 per share.
Click here for the full ASX Release
This article includes content from CLEO Diagnostics, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
